NASDAQ · Healthcare · Medical - Instruments & Supplies
Harvard Bioscience, Inc.
HBIO
Harvard Bioscience, Inc. CEO John Duke · Market cap $25.5M.
$5.71
+0.30 · +5.55%
52w hi $9.5052w lo $2.80
Off 52w high 27.8%
70
NOTABLE
Current InsiderScore
Corp · 90d
5
5 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
0 strong · 4 notable
Analyst consensus
Hold
Avg PT $6.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 17 | William Snider | Buy | 8,475 | $4.85 | +$41K | 65 | |
| Mar 17 | Stephen J Denelsky | Buy | 10,000 | $4.87 | +$49K | 68 | |
| Mar 16 | Mark T Frost | Chief Financial Officer | Buy | 5,000 | $5.00 | +$25K | 61 |
| Mar 16 | William Snider | Buy | 12,525 | $4.99 | +$62K | 70 | |
| Mar 16 | John D Duke | Chief Executive Officer | Buy | 5,000 | $5.01 | +$25K | 54 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay